Understanding these variables helps clinicians provide individualized counseling and helps patients maintain realistic expectations during the initial treatment phase
The best choice depends on current weight and BMI, weight-related medical conditions, blood sugar status, cardiovascular risk, liver health, kidney function, medication history, side-effect risk, muscle mass and nutrition status, cost and access, patient preference, and long-term maintenance planning
These combined effects on immune cells and direct myocardial protection underscore the multifaceted cardioprotective benefits of GLP-1R agonists [47]
The GLOW Peptide protocol changes the game
Cuenca Hernndez R, Segura Galindo A, Martnez Acebes E